| Bioactivity | Dovitinib (dilactic acid) is an orally active inhibitor of VEGF kinase. Dovitinib (dilactic acid) inhibits receptor tyrosine kinases (RTKs) involved in solid and hematologic cancers and tumor angiogenesis[1]. |
| Name | Dovitinib dilactic acid |
| CAS | 852433-84-2 |
| Formula | C27H33FN6O7 |
| Molar Mass | 572.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhu, S., et al. The Chemical Development of CHIR-258. CHIMIA International Journal for Chemistry, 60(9), 584–592. |
Dovitinib dilactic acid
CAS: 852433-84-2 F: C27H33FN6O7 W: 572.59
Dovitinib (dilactic acid) is an orally active inhibitor of VEGF kinase. Dovitinib (dilactic acid) inhibits receptor tyro
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.